Company: HRTX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-060882
Chunk: 67

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 67
---
 we expect brokers, banks or other nominees to have discretionary authority to vote on this proposal.

<div align='center'>The Board of Directors recommends a vote “FOR” the ratification of the appointment of Withum Smith+Brown, PC as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</div>

48

PROPOSAL 3 - ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION

At the Annual Meeting, our stockholders will have the opportunity to vote, on a nonbinding advisory basis, to approve the compensation of the Company’s Named Executive Officers, as identified in this Proxy Statement under the heading “Executive Compensation,” in accordance with Section 14A of the Exchange Act (also known as the “Say-on-Pay” vote). The Say-on-Pay vote is a nonbinding advisory vote on the compensation of our Named Executive Officers, as such compensation is disclosed pursuant to Item 402 of Regulation S-K in this Proxy Statement. The Say-on-Pay vote is not a vote on the Company’s general compensation policies, compensation of our Board or the Company’s compensation policies as they relate to risk management, but rather on the overall compensation of our Named Executive Officers and the philosophy, policies and practices with respect to such compensation described in this Proxy Statement. We currently hold our Say-on-Pay vote every year. We expect the next advisory Say-on-Pay vote will occur at the 2026 Annual Meeting.

The compensation paid to our Named Executive Officers is described in the compensation tables and the related narrative disclosure contained in this Proxy Statement. Pursuant to Section 14A of the Exchange Act, our Board is asking stockholders to cast a nonbinding advisory vote “FOR” the following resolution:

“RESOLVED, that the compensation paid to the company’s named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including Compensation Discussion and Analysis, the related compensation tables and narrative discussion, is hereby APPROVED.”

Although this vote is nonbinding, our Board values the views of our stockholders and will consider the outcome of the vote when determining future compensation arrangements for our Named Executive Officers.

Vote Required and Board Recommendation

The proposal to approve, on a nonbinding advisory basis, the compensation paid to our Named Executive Officers requires the affirmative vote of a majority of the votes properly cast on this proposal, provided a quorum is established. Abstentions and broker non-votes will have no effect on the outcome of this proposal.